Analyzing the proteostatic disequilibrium, pathway disruption, and developed insulin resistance in AD, we can also expect inhibitory activity of protein phosphatase 2A (PP2A) on NFT and Aβ deposition. The gene discussed is PTPA; the disease is Alzheimer disease.